Treace Medical Concepts Inc
NASDAQ:TMCI
Income Statement
Earnings Waterfall
Treace Medical Concepts Inc
Revenue
|
187.1m
USD
|
Cost of Revenue
|
-35.2m
USD
|
Gross Profit
|
151.9m
USD
|
Operating Expenses
|
-203.4m
USD
|
Operating Income
|
-51.4m
USD
|
Other Expenses
|
1.9m
USD
|
Net Income
|
-49.5m
USD
|
Income Statement
Treace Medical Concepts Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||
Revenue |
39
N/A
|
45
+14%
|
45
0%
|
50
+12%
|
57
+15%
|
65
+13%
|
78
+20%
|
85
+9%
|
94
+11%
|
105
+11%
|
114
+9%
|
126
+10%
|
142
+13%
|
155
+9%
|
167
+8%
|
175
+5%
|
187
+7%
|
|
Gross Profit | ||||||||||||||||||
Cost of Revenue |
(8)
|
(9)
|
(10)
|
(11)
|
(13)
|
(13)
|
(15)
|
(17)
|
(18)
|
(20)
|
(21)
|
(23)
|
(28)
|
(30)
|
(32)
|
(33)
|
(35)
|
|
Gross Profit |
32
N/A
|
36
+13%
|
35
-2%
|
39
+12%
|
45
+14%
|
51
+14%
|
62
+22%
|
68
+10%
|
77
+12%
|
85
+11%
|
93
+9%
|
102
+10%
|
114
+12%
|
125
+10%
|
135
+8%
|
141
+5%
|
152
+8%
|
|
Operating Income | ||||||||||||||||||
Operating Expenses |
(35)
|
(39)
|
(38)
|
(40)
|
(44)
|
(51)
|
(64)
|
(76)
|
(93)
|
(108)
|
(124)
|
(139)
|
(149)
|
(171)
|
(177)
|
(189)
|
(203)
|
|
Selling, General & Administrative |
(30)
|
(33)
|
(33)
|
(35)
|
(38)
|
(44)
|
(57)
|
(67)
|
(83)
|
(97)
|
(112)
|
(126)
|
(136)
|
(152)
|
(162)
|
(174)
|
(188)
|
|
Research & Development |
(5)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(14)
|
(14)
|
(14)
|
(15)
|
(15)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
|
Operating Income |
(4)
N/A
|
(3)
+17%
|
(3)
-4%
|
(1)
+80%
|
1
N/A
|
1
-28%
|
(2)
N/A
|
(7)
-287%
|
(17)
-127%
|
(23)
-41%
|
(31)
-34%
|
(37)
-19%
|
(35)
+6%
|
(45)
-30%
|
(42)
+8%
|
(48)
-16%
|
(51)
-7%
|
|
Pre-Tax Income | ||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(1)
|
(4)
|
(5)
|
(5)
|
(6)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(1)
|
1
|
2
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(5)
|
0
|
(0)
|
(0)
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(4)
N/A
|
(4)
+7%
|
(4)
-10%
|
(4)
+1%
|
(4)
+15%
|
(4)
-21%
|
(8)
-69%
|
(11)
-49%
|
(21)
-81%
|
(27)
-32%
|
(39)
-45%
|
(45)
-15%
|
(43)
+5%
|
(47)
-10%
|
(42)
+11%
|
(48)
-13%
|
(50)
-4%
|
|
Net Income | ||||||||||||||||||
Income from Continuing Operations |
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(8)
|
(11)
|
(21)
|
(27)
|
(39)
|
(45)
|
(43)
|
(47)
|
(42)
|
(48)
|
(50)
|
|
Net Income (Common) |
(5)
N/A
|
(5)
+6%
|
(5)
-9%
|
(5)
+1%
|
(4)
+14%
|
(5)
-19%
|
(8)
-58%
|
(12)
-44%
|
(21)
-77%
|
(27)
-31%
|
(39)
-45%
|
(45)
-15%
|
(43)
+5%
|
(47)
-10%
|
(42)
+11%
|
(48)
-13%
|
(50)
-4%
|
|
EPS (Diluted) |
-0.1
N/A
|
-0.09
+10%
|
-0.1
-11%
|
-0.1
N/A
|
-0.09
+10%
|
-0.12
-33%
|
-0.18
-50%
|
-0.24
-33%
|
-0.43
-79%
|
-0.5
-16%
|
-0.71
-42%
|
-0.81
-14%
|
-0.77
+5%
|
-0.8
-4%
|
-0.68
+15%
|
-0.79
-16%
|
-0.81
-3%
|